and use dividers or labels

Include recent training logs and meeting notes

2. Source Documents and SDV Readiness

• Ensure all source documents are complete, legible, and signed
• Label subject records clearly with screening/enrollment IDs
• Match source entries with corresponding CRF entries
• Resolve any open data queries in the EDC

3. Subject Status and Visit Schedule

• Have a summary of enrolled subjects with visit windows and completion status
• Update the screening and enrollment log
• Flag missed visits or out-of-window visits in the deviation log

4. Investigational Product (IP) Accountability

• Ensure the IP is stored securely under controlled conditions
• Maintain up-to-date dispensing and return logs
• Label storage areas and assign responsible personnel
• Prepare accountability logs for CRA review

5. Adverse Event and SAE Documentation

• Verify that all AEs/SAEs are properly recorded and reported
• Ensure narratives and follow-up documentation are filed
• Confirm that safety reports from the sponsor are acknowledged and filed

6. Deviation and CAPA Logs

• Maintain a log of protocol deviations with corrective actions
• Include CAPA documentation where applicable
• Ensure that repeated deviations are discussed and mitigated

7. Subject Confidentiality

• Ensure personal identifiers are secured and not accessible to unauthorized personnel
• Redact identifiers if necessary in shared documentation

8. Laboratory and ECG Reports

• Ensure all labs are filed in subject folders
• Flag abnormal values and their resolution or PI review
• Include ECG reports and physician interpretations if required by protocol

9. Follow-Up on Previous Visit Findings

• Address all previous action items listed in the CRA’s last Monitoring Visit Report (MVR)
• Document steps taken and file resolutions in the ISF
• Notify CRA if additional information is needed

Tools for Streamlined RMV Preparation

• Use RMV readiness checklists from Pharma SOP templates
• Maintain eTMF and EDC systems regularly
• Use dashboards to monitor upcoming subject visits and CRA interactions

Best Practices for RMV Readiness

1. Conduct a self-audit 2–3 days before the CRA visit
2. Ensure delegated team members are trained and informed
3. Avoid last-minute preparations—build visit readiness into routine site workflow
4. Schedule time with the PI for CRA discussions if required
5. Organize printed materials and backup documentation if electronic systems fail

Common Site Pitfalls and How to Avoid Them

• Missing documentation in ISF or scattered filing
• Unresolved SDV queries or CRF discrepancies
• Outdated delegation logs or missing PI signatures
• Lack of accountability over investigational product
• Inaccessibility of subject records on visit day

Final Day-of-Visit Tips

• Ensure the site coordinator is available throughout the visit
• Offer a quiet, clean workspace to the CRA
• Provide Wi-Fi and system access details beforehand
• Have an on-site contact available in case the CRA needs clarifications

Conclusion

Preparing for an RMV is an ongoing process, not a one-time activity. By integrating this checklist into your site’s operational routines, you not only streamline CRA interactions but also boost trial quality and compliance. Remember, RMV preparedness reflects your site’s commitment to ethical, efficient, and GCP-compliant research practices. For guidance on stability-related documentation, refer to Stability Studies or browse additional GMP compliance resources.